Sanofi-Aventis Deutschland GmbH
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Germany
- Registered address
- Brüningstr. 50, Frankfurt am Main, 65926, Germany (DEU)
- Operations here
- analysisapi manufacturelabelmanufacturepack
- FDA identifiers
- FEI 3003195501 · DUNS 313218430
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2022-03-25
- VAIDrug Quality Assurance2019-05-14
- VAIDrug Quality Assurance2017-03-03
- VAIDrug Quality Assurance2015-06-26
- NAIDrug Quality Assurance2013-12-05
- VAIDrug Quality Assurance2013-07-02
- NAIDrug Quality Assurance2012-04-30
- VAIDrug Quality Assurance2011-07-14
- OAIDrug Quality Assurance2010-09-16
- VAIDrug Quality Assurance2008-10-31
Drugs this plant is listed as making
18 distinct drugs across 44 products name this site in their FDA label.
- AlemtuzumabGenzyme Corporation
- alirocumabSanofi-Aventis U.S. LLC
- cabazitaxelSanofi-Aventis U.S. LLC
- cemiplimab-rwlcRegeneron Pharmaceuticals, Inc.
- DocetaxelSanofi-Aventis U.S. LLC
- DupilumabSanofi-Aventis U.S. LLC
- enoxaparin sodiumFresenius Kabi USA, LLC
- fitusiranGenzyme Corporation
- insulin aspart-szjjSanofi-Aventis U.S. LLC
- insulin glargineSanofi-Aventis U.S. LLC
- insulin glargine and lixisenatideSanofi-Aventis U.S. LLC
- insulin glulisinesanofi-aventis U.S. LLC
- insulin lisproSanofi-Aventis U.S. LLC
- leflunomidesanofi-aventis U.S. LLC
- oxaliplatinWinthrop U.S, a business of sanofi-aventis U.S. LLC
- sarilumabSanofi-Aventis U.S. LLC
- teriflunomideGenzyme Corporation
- ziv-afliberceptsanofi-aventis U.S. LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.